Panasonic Intellectual Property Management Co., Ltd.

Sanofi-aventis

Mitsubishi Tanabe Pharma Corporation

Hiroshi Iwamura

Hiroshi Iwai

Kazutoshi Watanabe

Osamu Shibata

Hirofumi Nishimura

Masahiro Okuyama

Asako Hamada

Fumiaki Uehara

Yunyun Cao

Tomohiro Honda

Tomohito Nagata

An image capture control device includes a recognition unit that determines whether a peripheral situation corresponds to a predetermined situation based on image data, and a controller that controls an infrared light irradiation unit to increase a pulse number of transmission pulses to be emitted to a target, when the recognition unit determines that the peripheral situation corresponds to the predetermined situation.

Image capture control device, image capture control method, and recording medium

A first data group, which indicates reflection wave intensities from reflection points for radar directions indicating directions in which the corresponding reflection points exist relative to a radar apparatus and distances from the radar apparatus to the reflection points, and a second data group, which indicates Doppler velocities of the reflection points for the radar directions and the distances from the radar apparatus to the reflection points, are used to generate a third data group, which indicates the reflection wave intensities of the reflection points. A radar moving direction relative to a moving direction of the vehicle for each frame is generated based on the third data group. The radar moving direction when the moving direction of the vehicle is straight ahead is estimated using the radar moving direction in a predetermined number of frames, and the radar installation angle is calculated using the estimated radar moving direction.

Radar-installation-angle calculating device, radar apparatus, and radar-installation-angle calculating method

Production method of an optically active morpholine compound represented by the formula 10, or a compound represented by the formula 55, which includes the following steps:  wherein each symbol is as defined in the specification. An optically active 2-aryl-substituted morpholine compound and 3-oxo-3-(pyrimidin-4-yl)propionate, which are important as starting materials for synthesizing 2-(2-arylmorpholin-4-yl)-1-methyl-1H-[4,4']bipyrimidinyl-6-one having a tau protein kinase 1 inhibitory activity and useful as a therapeutic drug for Alzheimer's disease and the like, can be produced in a high yield by an industrially advantageous method.

Intermediate compound for synthesizing pharmaceutical agent and production method thereof

Growing community of inventors

Osaka, Japan

Hiroshi Iwamura